Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
47.61
+0.01 (0.02%)
At close: Sep 12, 2025, 4:00 PM EDT
47.55
-0.06 (-0.13%)
After-hours: Sep 12, 2025, 7:59 PM EDT

Tourmaline Bio Stock Forecast

Stock Price Forecast

The 11 analysts that cover Tourmaline Bio stock have a consensus rating of "Hold" and an average price target of $46.95, which forecasts a -1.39% decrease in the stock price over the next year. The lowest target is $25 and the highest is $58.

Price Target: $46.95 (-1.39%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$25$46.95$48$58
Change-47.49%-1.39%+0.82%+21.82%

Analyst Ratings

The average analyst rating for Tourmaline Bio stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy333330
Buy444443
Hold000008
Sell000000
Strong Sell000000
Total7777711

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Piper Sandler
Piper Sandler
Hold
Downgrades
$65$48
HoldDowngrades$65$48+0.82%Sep 11, 2025
Truist Securities
Truist Securities
Hold
Downgrades
$63$48
HoldDowngrades$63$48+0.82%Sep 10, 2025
Guggenheim
Guggenheim
Hold
Downgrades
$55$48
HoldDowngrades$55$48+0.82%Sep 10, 2025
Chardan Capital
Chardan Capital
Hold
Downgrades
$70$48
HoldDowngrades$70$48+0.82%Sep 10, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
$50$48
HoldDowngrades$50$48+0.82%Sep 10, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
7.65M
Revenue Next Year
7.65M
from 7.65M
EPS This Year
-3.53
from -2.89
EPS Next Year
-4.37
from -3.53
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
----7.65M7.65M16.03M
Revenue Growth
------109.53%
EPS
-0.08-22.46-8.87-2.89-3.53-4.37-5.41
EPS Growth
-------
Forward PE
-------
No. Analysts
----131210
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High63.0M63.0M
Avg7.7M7.7M
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High-
723.5%
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-1.89-3.06
Avg-3.53-4.37
Low-4.01-5.42

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.